AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...

Shanghai-based Fosun Pharmaceutical has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 ...

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...

With rapid innovations in biotechnology, companies are developing groundbreaking therapies and diagnostic tools that address ...

Several of these commercialized cell therapies have emerged as top-selling drugs in the healthcare sector. For example, Gilead Sciences reported that Yescarta achieved sales exceeding USD 1.5 billion, ...

Public health groups raise concern on patent grant to promising, new HIV drug Patient and public health groups have raised concerns over a potential patent grant to Gilead Sciences for the HIV drug ...

A Senate hearing Tuesday will look at why the list prices of Ozempic and Wegovy are much higher in the U.S. than in ...

I hope you found this article useful. Please let me know if you have any ideas for improving the format or data included in this series. Editor's Note: This article discusses one or more securities ...

Global Hepatocyte Growth Factors (HGFs) market is valued at approximately USD 70.3 million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2024 ...

The stories of fallen IDF soldiers Yosef Malachi Guedalia, Dekel Suisa, and Aviad and Erez Deri – and those who mourned them at Mount Herzl military cemetery, months and years later. The police ...

Sheriff Christina Corpus maintains Supervisor Ray Mueller "should have the facts before weighing in on ...

Packers RB Josh Jacobs on Titans DT Jeffery Simmons' run-stopping goal: 'They're a physical team, so we're going to see' ...